This country profile provides an overview of Angola’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
2%
Blinding trachoma
N/A
Intestinal
25%
Bilharzia
45%
River blindness
4%
3.15 million people received treatment in Angola in 2017 11.59 million people did not receive treatment in Angola in 2017

Priorities for progress in Angola

  • Angola is commended for taking positive steps to improve the coverage of intestinal worms, by securing a grant from the World Bank Trust Fund and for the development of a national health strategy for NTDs.
  • As a next step, Angola should work to fully integrate the treatment of NTDs, including elephantiasis and river blindness, whilst increasing coverage across the board.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage slightly increased from 1% in 2016 to 2% in 2017.

People needing treatment
3.97m
People receiving treatment
0.09m

Blinding trachoma

Angola does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 27% in 2016 to 25% in 2017.

Pre sch and school-aged children needing treatment
11.54m
Pre sch and school-aged children receiving treatment
2.84m

Bilharzia

Treatment coverage decreased from 50% in 2016 to 45% in 2017.

School-aged children needing treatment
3.85m
School-aged children receiving treatment
1.72m

River blindness

Treatment coverage slightly increased from 2% in 2016 to 4% in 2017.

People needing treatment
5.56m
People receiving treatment
0.23m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Angola.